Infosys' stock rises toward 6-month high, and longest monthly win streak in 9 years
Shares of Infosys Ltd. (500209.BY) rose 0.5% toward a six-month high in morning trading Tuesday, to buck the selloff in the technology sector and the broader stock market. The information-technology consultant's stock has now gained 3.9% so far in September, putting it on track for a fifth-straight monthly gain, which would be the longest such streak since the six-month win streak that ended November 2014. Meanwhile, the Technology Select Sector SPDR ETF (XLK) was down 1.3% and the S&P 500 was off by 0.5%. The stock's rally Tuesday comes after President Joe Biden wrapped up a trip to Vietnam and India this week -- the Group of 20 summit over the weekend was held in New Delhi -- as he looked to strengthen partnerships and develop new collaborations with the countries, while denying it was to fend off China's attempts to increase its influence in the region. Infosys's stock has now run up 22.0% since it closed at a 2 1/2-year low of $14.79 on April 25, compared with a 12.6% gain in the iShares MSCI India ETF (INDA) and a 9.7% advance in the S&P 500 over the same time.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-12-23 1107ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom